Summary of findings from the study and speculations from previous research. (Nishiwaki et al., npj Parkinson's Disease, 2024) ...
Two years ago, Sharon Chakkalackal of Toronto, Ont., was given a diagnosis she never expected — young-onset Parkinson’s ...
Brett Favre has opened up about living with Parkinson’s disease, saying he often wakes up feeling as stiff as “a board.” The ...
New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.
SPR301 is a potential best-in-class gene therapy candidate that delivers a more stable, rationally engineered version of GCase, the enzyme ...
The disease is characterized by progressive motor, cognitive, and psychiatric decline. Three treatments are approved to treat ...
Davis Joseph discovered what could not be found for the last 17 years: the fundamental neurobiological mechanism of 4E-BP2 ...
A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of Iowa Health Care researchers.
Blarcamesine’s safety profile indicates not requiring routine MRI monitoring, and the advantage of blarcamesine is that it is a small oral molecule that exerts clinical benefits on cognition and ...
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of Alzheimer's disease, ...